Graphene Oxide in the Human Body Controlled through a Smartphone! Study on Transhumanist Electromagnetic Nanotherapy
by Fabio Giuseppe Carlo Carisio
«This study focuses on the development of a new electric field responsive graphene oxide (GO) nanoparticle system for on-demand drug delivery».
Thus begins the summary of Indian research on the use of the infamous GO, an exclusively synthetic carbon allotrope, which confirms the experimental studies started in the USA and the European Union for the biomedical use of this dangerous nanomaterial in symbiosis with radio frequencies .
The title is already extremely eloquent: “Remotely controlled electro-responsive on-demand nanotherapy based on amine-modified graphene oxide for synergistic dual drug delivery”.
It takes on a disturbing value in relation to the research that has highlighted the presence of GO in Covid vaccines and the very well-founded fears that these nanoforms can be controlled remotely with a smartphone, especially with the most powerful 5G repeaters.
The study, in fact, confirms this possibility denied by the scientific community which wants to continue its experiments without too many bioethical constraints…
The research was published in September 2022 by ScienceDirect in the MaterialstodayChemistry section after a peer review which confirmed its reliability and is signed by scientists Dibakar Sahoo, School of Physics, Sambalpur University, JyotiVihar, Burla, Odisha, Tapas Mitra, Department of Biochemistry , University of Calcutta, Kolkata, Kaushik Chakraborty, Computer Science and Technology Department, The Calcutta Technical School, Priyatosh Sarkar, Bharat Pharmaceutical Technology, Amtali, West Tripura, Tripura.
The Mobile Phone to Check Graphene in the Human Body
The immediately disturbing aspect of the research concerns the verification of the functionality of the combination “electromagnetic stimulus – graphene oxide” without analyzing in depth the danger of this substance which normally appears in very thin sheets or tubes of nanometric dimensions and therefore detectable only with powerful electron microscopes.
«Today, GO is an attractive option adopted in various biological applications for its exclusive features such as flexibility, conductiveness, cost-effectiveness, and external stimuli-responsive nature. It is usual to utilize multiple drugs in cancer treatment. This kind of therapy has lesser side-effects, drug resistance, and is more effective than utilizing only one drug. This study aims to determine low-voltage-controlled dual drug (aspirin and doxorubicin) release from GO surface» write the Indian scientists.
In the abstract of the research they highlight the functional benefits of the use of nanomaterials without making any mention of their danger due to the damage they can cause to human cells which has been highlighted by multiple scientific research as highlighted by Gospa News in the investigation on biotechnology ” with toxicology not thoroughly studied” of the anti-Covid mRna gene serum Comirnaty (produced by Pfizer-Biontech) in which some chemical studies have detected the presence of graphenic nanoparticles.
«Here, we have demonstrated how to control the drug release rate remotely with a handy mobile phone, with zero passive release at idle time – reads the Indian research published on ScienceDirect – In addition, the study focused to estimate the synergism of aspirin with doxorubicin in the release mechanism from GO in the presence of external voltage, using the spectroscopic method. Moreover, we observed aspirin- and doxorubicin-induced synergistic antitumor activity in MDA-MB 231 (breast cancer cell) in vitro. Thus, our study presents a noble combination of aspirin and doxorubicin that could be utilized for remotely controlled on-demand drug delivery for triple negative breast cancer treatment, using GO as a carrier».
Graphene Oxide in Studies on Covid Vaccines and the Brain
The same nanomaterial was tested in two research projects funded by the European Commission both as a vehicle for messenger RNA in a test for a vaccine against SARS-Cov-2, the Covid-19 virus, but also as a tool for inoculating a gene therapy to produce “design immunity”, i.e. a synthetic antibody calibration that opens the doors of transhumanism to medical biochemistry.
In the latter case, the outcome for the mice used as laboratory guinea pigs was fatal: a fulminant tumor similar to those forms of turbo-cancer that are being recorded in Covid vaccinated people and which 4 studies have already put in hypothetical correlation with mRNA gene sera.
A Chinese pharmaceutical company also patented an antiSARS-Cov-2 mRNA vaccine with graphene oxide but mysteriously never presented the candidacy of this drug as an antidote against Covid-19.
«For last few years, stimuli-responsive materials have revolutionized the world of biomedicines and biotechnology – explained the Indian scientists – Therapeutic agents can be released from stimuli-responsive drug delivery systems by many endogenous factors such as temperature, pH, biomolecules like enzymes, and so on [, , , ]. However, in this process, the main challenge is to locate the drug in a diseased tissue particularly, but not in the healthy tissue, especially when the difference between these tissues is quite negligible; hence raises a possibility of off-target release. In contrast, all these obstacles can be lifted by introducing exogenous factors such as magnetic field, light, heat, voltage are totally separated from the patient’s physiology and can deliver the drug in a more controlled and precise way in the targeted region [5,6].
This type of experimentation had already been conducted by the Pentagon’s military agency DARPA during the Obama-Biden administration to use graphene oxide as an “antenna” for an external electromagnetic stimulus functional to the treatment of neurocerebral pathologies such as epilepsy but obviously also applicable as a bio-weapon to create “pilotable” human beings or insert substances reactive to potentially lethal electromagnetic waves into enemies.
The project was then suddenly closed by DARPA (Defense Advanced Research Projects Agency) but reappeared among the main objectives of the Graphene Flagship financed by the European Commission thanks to which the study of the International School for Advanced Studies (Sissa) of Trieste relating to reactivity was carried out in GO light verified by injecting graphene flakes into the hippocampus (part of the brain).
Compared to this research, the experimentation of Indian scientists certainly appears to have less impact but no less disturbing:
Graphene as a Carrier for Drugs against Breast Cancer
«In the present study, our strategy is to develop a graphene oxide (NGO) nanocomposite functionalized with two different drug molecules one is a common anticancer drug for breast cancer, doxorubicin (DOX), and another one is a non-steroidal anti-inflammatory drug, acetylsalicylic acid or aspirin (ASP)» Asian researchers explain in more detail.
«In this study, we used NGO as an electro-sensitive material to deliver drugs in a controllable manner. In this study, NGO is first modified with an amine group to functionalize it with ASP. This modified ASP-tagged NGO is used for loading anticancerous drug DOX. This drug-loaded NGO then passes through the mobile-controlled external electrical stimulation, which triggers the release of both the drugs (ASP and DOX)» we can still read it in the research.
The “Minimum” Toxicity of the Nanocompound without Data…
«In vitro anticancer activity of the prepared nanocomposite was evaluated by performing MTT assay (Fig. 9a). In this study, we have evaluated the anticancer activity of the nanomedicine with or without applying electrical stimulation and compared to free DOX. Very interestingly, GO–NH–ASP-DOX with 2.7v electrical field has shown superior anticancer activity, whereas free DOX has shown its conventional toxicity pattern , and the GO–NH–ASP-DOX nanocomposite also has shown minimal toxicity» write the Indian scientists, limiting the crucial point on the safety of the nanomaterial to a single line, devoid of objective documentation.
«In conclusion, we have shown here that NGO can be used as a dual drug delivery agent, and the release of drugs can be controlled by an external voltage. To exploit the synergic effect of ASP and DOX, we modified NGO and attached two drugs to it. Our labmade remote-controlled device efficiently released the anticancer drug. The releasing process can easily be switched on and off with a mobile phone by changing the bias voltage. Here, the release of DOX from NGO under the influence of external» the study concludes.
In the biomedical era projected towards transhumanism the main objective is to demonstrate that something works. The bioethical problem of what consequences it may entail for people represents a secondary question that will only concern human laboratory guinea-pigs.
Or the unaware ones who will find themselves drinking potable water filtered by graphene or will be examined with RT PCR swabs based on the same substance without even knowing it…